4//SEC Filing
KBL IV SPONSOR LLC 4
Accession 0001213900-20-040310
CIK 0001690080other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 7:00 PM ET
Size
13.5 KB
Accession
0001213900-20-040310
Insider Transaction Report
Form 4
KBL IV SPONSOR LLC
10% Owner
Transactions
- Sale
Common Stock
2020-11-17$2.26/sh−3,300$7,445→ 2,684,516 total(indirect: See footnote) - Sale
Common Stock
2020-11-23$3.26/sh−60,633$197,676→ 2,583,738 total(indirect: See footnote) - Sale
Common Stock
2020-11-18$2.31/sh−6,700$15,480→ 2,677,816 total(indirect: See footnote) - Sale
Common Stock
2020-11-25$2.78/sh−12,182$33,809→ 2,571,556 total(indirect: See footnote) - Sale
Common Stock
2020-11-19$2.12/sh−33,445$70,837→ 2,644,371 total(indirect: See footnote)
KRAUSS MARLENE
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2020-11-18$2.31/sh−6,700$15,480→ 2,677,816 total(indirect: See footnote) - Sale
Common Stock
2020-11-25$2.78/sh−12,182$33,809→ 2,571,556 total(indirect: See footnote) - Sale
Common Stock
2020-11-17$2.26/sh−3,300$7,445→ 2,684,516 total(indirect: See footnote) - Sale
Common Stock
2020-11-23$3.26/sh−60,633$197,676→ 2,583,738 total(indirect: See footnote) - Sale
Common Stock
2020-11-19$2.12/sh−33,445$70,837→ 2,644,371 total(indirect: See footnote)
Footnotes (1)
- [F1]The shares are held directly by KBL Sponsor. Dr. Marlene Krauss, the former Chief Executive Officer, and a former memeber of the Board of Directors, of the issuer, is the sole managing member of KBL Sponsor. Consequently, she may be deemed the beneficial owner of the shares of common stock held by KBL Sponsor, and she has sole voting and dispositive control over such securities. Dr. Krauss disclaims beneficial ownership over any securities owned by KBL Sponsor in which she does not have a pecuniary interest.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001706868
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 7:00 PM ET
- Size
- 13.5 KB